비비에이치씨

Human nEPS cells derived Osteocyte. (S-osteo)

S-osteo

Osteocyte differentiated from nEPS(pluripotent stem cell)

Cell Type	Osteocyte differentiated from nEPS(pluripotent stem cell)
Reprogramming Method	Epigenetics by STC-F002
Disease	None
Gender	Male
Designations	Human bone
Species	Homo sapiens, human
Origin	Mesenchymal stem cell derived from umbilical cord
Shipping information	Distributed frozen (volume : 1mL)

Store Temp. Liquid Niliozen Vapor Phase ( -130℃ or colder )
Biosafty Level : 1

Description

STRI became the world’s first commercial provider of human osteoblast cell differentiated from human pluripotent stem cell (nEPS) without side effect and services.

This osteoblast is derived from Mesenchymal stem cells (MSC) isolated from umbilical cords of healthy donor

nEPS(newly Elicited Pluripotent Stem cell without side effects by natural products) is produced from MSC to reprogram pluripotency gene expression (OCT4, SOX2, Nanog, ETC) by treating STC-F002.

In addition, nEPS is not occurred tumor to be remarkably low expression of C-Myc gene related oncogene. Induction of nEPS do not have artificial manipulate anything and use only STC-F002 treatment, small molecules extract from natural products.

Our osteoblast cell line will have enormous contribution to understanding the mechanism of human bone development and support treatment source of various bone disease.

[이 게시물은 최고관리자님에 의해 2020-12-29 10:30:00 Products에서 복사 됨]

BACK